High-Risk Prostate Cancer

Understanding Treatment for High-Risk Prostate Cancer | Prostate Cancer Staging Guide

Prostate Cancer Research Institute

The role of radiation in managing high-risk localized prostate cancer

Dr. Nguyen on the Optimal Duration of ADT in High-Risk Prostate Cancer

Overview of Azure (High-Risk) Prostate Cancer | Prostate Cancer Staging Guide

Prostate Cancer Research Institute

Dr. Kearns on the Role of Surgery in High-Risk Prostate Cancer

Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer

Treating High-Risk Gleason 8: A Modern Approach | Mark Scholz, MD | PCRI

Prostate Cancer Research Institute

Billy Plott's battle with prostate cancer | Check Up 13

WTHR

Hormone Therapy for High-Risk Prostate Cancer | Prostate Cancer Staging Guide

Prostate Cancer Research Institute

Localized high-risk prostate cancer: updated results from 12-year follow up of GETUG-12

Dr. Nguyen on Treatment Considerations in High-Risk Prostate Cancer

Evaluation of a High-Risk Prostate Cancer Patient

Targeted Oncology

Therapy Approach in High-Risk Prostate Cancer

Targeted Oncology

PREDICT-RT Study for Patients with High-Risk Prostate Cancer

High-Risk Prostate Cancer

MUSC Hollings Cancer Center

Neoadjuvant androgen deprivation therapy in men with high-risk localized prostate cancer

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRI

Prostate Cancer Research Institute

High-Risk Prostate Cancer: Benefit to adding 2nd Generation Hormone Therapy or Chemo? | PCRI

Prostate Cancer Research Institute

Dr. Koontz Discusses LHRH in High-Risk Prostate Cancer

Who to Screen: Finding the High-Risk Prostate Cancer Patient